India’s coronavirus data has faced serious concerns over its accuracy, meaning COVID-19’s impact in the country could actually be much more severe.
India set a tragic new COVID-19 world record on Wednesday after officials announced that over 4,500 people died from the virus in a 24-hour window.
That death toll beat the previous record of 4,400, which was set by the United States on January 20. If there’s a silver lining to this, it’s that the total number of new daily cases seems to finally be declining. Between April and May, the number of daily new cases exploded, peaking at more than 414,000 on May 6. However, this week, it’s down to an average of about 300,000 new daily cases.
Still, there have consistently been doubts about the accuracy of India’s COVID-19 case numbers regarding both the country’s total death toll and new daily cases. India, with its vast rural regions and population, often struggles to get accurate numbers from these groups.
These, often impoverished, communities are having people die with COVID-like symptoms without ever getting tested. Experts believe that the high death toll will continue for weeks, especially if the government is able to more accurately test and record its remote populations.
Black Fungus Outbreaks
Adding to the problems is that an alarming number of COVID-19 patients in India are also combating black fungus. The fungus, scientifically known as mucormycosis, has a mortality rate of 50% for its least deadly strains, and upwards of 90% for its worst. Often, the only remedy to save someone is to remove jaws or eyes.
The fungus flourishes in warm, damp environments and is often found in older buildings and in developed regions of the world. It’s pretty rare but dangerous and far more prevalent in India’s less developed regions. Together with COVID-19, it can ravage a victim’s respiratory system and is extremely deadly. In immuno-compromised people, such as those with COVID-19, mortality rates reach nearly 100%.
Beyond the tragic loss of life in India, there are also international concerns over how the virus is progressing there as India is home to its own variants of COVID-19. One such variant, labeled B.1.617.2 by the World Health Organization this month, has scientists worried over indications that antibodies from vaccines or prior infections with other variants aren’t quite as effective.
This has led to concerns about reopening plans worldwide if the variant is able to get out into the world population more than it already has, as it has recorded cases in the U.K., U.S., and many other countries.
While it’s believed that even though antibodies for “normal” variants of COVID-19 aren’t as effective against B.1.617.2, they’re still better than nothing, which is why experts are still encouraging vaccination. Some, such as the CEO of BioNTech, claim that vaccines are upwards of 75% effective; although more research is still needed.
See what others are saying: (BBC) (Washington Post) (Reuters)
U.K. Court Rules Julian Assange Can Be Extradited to U.S.
The judgment overrules a lower court decision that blocked the WikiLeaks founder’s extradition on the grounds that his mental health was not stable enough to weather harsh conditions in the American prison system if convicted.
New Developments in Assange Extradition Battle
A British court ruled Friday that WikiLeaks founder Julian Assange can be extradited to the United States to face charges of violating the Espionage Act that could land him in prison for decades.
Prosecutors in the U.S. have accused Assange of conspiring with former army intelligence analyst Chelsea Manning in 2010 to hack into a Department of Defense computer network and access thousands of military and diplomatic records on the wars in Afghanistan and Iraq.
The information obtained in the hack was later published by WikiLeaks in 2010 and 2011, a move U.S. authorities allege put lives in danger.
In addition to a charge of computer misuse, Assange has also been indicted on 17 espionage charges. Collectively, the charges carry a maximum prison sentence of 175 years.
The Friday decision from the High Court overturns a lower court ruling in January, which found that Assange’s mental health was too fragile for the harsh environment he could face in the U.S. prison system if convicted.
Notably, the January ruling did not determine whether or not Assange was guilty. In fact, District Judge Vanessa Baraitser explicitly rejected the defense’s arguments that the charges against him were politically motivated and that he should be protected under freedom of press.
However, she agreed that the defense had provided compelling evidence that Assange suffers from severe depression and that the conditions he could face in the U.S. prison system were “such that it would be oppressive to extradite him to the United States of America.”
The U.S. appealed the ruling, arguing that Assange’s mental health should not be a barrier to extradition and that the psychiatrist who examined him had been biased.
In October, the Biden administration vowed that if Assange were to be convicted, he would not be placed in the highest-security U.S. prison or immediately sent to solitary confinement. Officials also said that the native Australian would be eligible to serve his sentence in his home country.
High Court Ruling
The High Court agreed with the administration’s arguments in its ruling, arguing that the American’s assurances regarding the conditions of Assange’s potential incarceration were “sufficient.”
“There is no reason why this court should not accept the assurances as meaning what they say,” the ruling stated. “There is no basis for assuming that the USA has not given the assurances in good faith.”
Assange’s fiancé, Stella Moris, said in a statement that his legal team would appeal the decision to the British Supreme Court at the “earliest possible moment,” referring to the judgment as a “grave miscarriage of justice.”
The Supreme Court will now decide whether or not to hear the case based on if it believes the matter involves a point of law “of general public importance.” That decision may take weeks or even months.
If the U.K. Supreme Court court objects to hearing Assange’s appeal, he could ask the European Court of Human Rights to stay the extradition — a move that could set in motion another lengthy legal battle in the already drawn-out process.
Assange and his supporters claim he was acting as an investigative journalist when he published the classified military cables. They argue that the possibility of his extradition and prosecution represent serious threats to press freedoms in the U.S.
U.S. prosecutors dispute that Assange acted as a journalist, claiming that he encouraged illegal hacking for personal reasons.
See what others are saying: (The New York Times) (NPR) (The Washington Post)
Early Data Indicates Omicron is More Transmissible But Less Severe
The studies come as Pfizer and BioNTech claim that preliminary research shows a third shot of their COVID vaccine appears to provide sufficient protection against the new variant, but two doses alone may not.
More Information About Omicron
Several preliminary studies published in recent days appear to show that the new omicron COVID-19 variant may be more transmissible but less severe than previous strains.
One recent, un-peer-reviewed study by a Japanese scientist who advises the country’s health ministry found that omicron is four times more transmissible in its initial stage than delta was.
Preliminary information in countries hit hard by omicron also indicates high transmissibility. In South Africa — where the variant was first detected and is already the dominant strain — new COVID cases have more than doubled over the last week.
Health officials in the U.K. said omicron cases are doubling every two or three days, and they expect the strain to become dominant in the country in a matter of weeks.
In a statement Wednesday, World Health Organization Director Tedros Adhanom Ghebreyesus said that while early data does seem to show high transmissibility, it also indicates that omicron causes more mild cases than delta.
Centers for Disease Control and Prevent Director Rochelle Walensky echoed that sentiment, telling reporters that of the 40 known omicron cases in the U.S. as of Wednesday, nearly all of them were mild. One person has been hospitalized so far and none have died.
Studies on Vaccine Efficacy
Other recent studies have shown that current COVID vaccines are effective at preventing severe illness and death in omicron patients, and boosters provide at least some added protection.
On Wednesday, Pfizer and BioNTech announced that laboratory tests have shown a third dose of their COVID-19 vaccine appears to provide sufficient protection against the omicron variant, though two doses may not.
According to the companies, researchers saw a 25-fold reduction in neutralizing antibodies for omicron compared to other strains of the virus for people who had just two Pfizer doses.
By contrast, samples from people one month after they had received a Pfizer booster presented neutralizing antibodies against omicron that were comparable to those seen against previous variants after two doses.
Still, Pfizer’s chief executive also told reporters later in the day that omicron could increase the likelihood that people might need a fourth dose earlier than previously expected, which he had initially said was 12 months after the third shot.
Notably, the Pfizer research has not yet been peer-reviewed, and it remains unclear how omicron will operate outside a lab, but other studies have had similar findings.
See what others are saying: (The New York Times) (Bloomberg) (NBC News)
40 Camels Disqualified From Beauty Contest After Breeders Inject Their Faces With Botox
The animals were barred from competing for $66 million in prizes at this year’s King Abdulaziz Camel Festival in Saudi Arabia.
Camels Booted From Beauty Contest
More than 40 camels were disqualified from a beauty contest in Saudi Arabia this week after judges found artificial enhancements in their faces, marking the biggest crackdown on contestants in the competition to date.
The animals were competing for $66 million in prizes at the King Abdulaziz Camel Festival, a month-long event that is estimated to include around 33,000 camels.
However, according to The Guardian, they were forced out of the contest when authorities found that breeders had “stretched out the lips and noses of the camels, used hormones to boost the animals’ muscles, injected heads and lips with Botox to make them bigger, inflated body parts with rubber bands, and used fillers to relax their faces.”
Those types of alterations are banned since judges look at the contestant’s heads, necks, humps, posture, and other features when evaluating them.
An announcement from the state-linked Saudi Press Agency said officials used “specialized and advanced” technology to detect tampering.
“The club is keen to halt all acts of tampering and deception in the beautification of camels,” the SPA report added before warning that organizers would “impose strict penalties on manipulators.”
While it’s unclear what that actually entails, this isn’t the first time people have tried to cheat in this way.
In 2018, 12 camels were similarly disqualified from the competition for injections in their noses, lips, and jaw.